Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 149.725K |
Day Range | - - - |
52 Wk Range | 0.232 - 3.680 |
Market Cap | $2.377M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 1.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dermata Therapeutics (NASDAQ: DRMA) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Dermata Therapeutics (NASDAQ: DRMA) was reported by Maxim Group on Thursday, March 23, 2023. The analyst firm set a price target for 4.00 expecting DRMA to rise to within 12 months (a possible 1021.08% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $0.3568 last updated April 25, 2024 at 1:09 AM EDT.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.